Formation and activity of NLRP3 inflammasome and histopathological changes in the lung of corpses with COVID-19

被引:0
|
作者
Morteza Gholaminejhad
Mehdi Forouzesh
Babak Ebrahimi
Seyed Amirhosein Mahdavi
Seyed Davood Mirtorabi
Amirreza Liaghat
Seyed Jalil Monabati
Muhammad Obaid Hamza
Gholamreza Hassanzadeh
机构
[1] Legal Medicine Organization,Legal Medicine Research Center
[2] Tehran University of Medical Sciences,Department of Anatomy, School of Medicine
[3] Legal Medicine Research Center,Department of Medical Laboratory Techniques, College of Medical Technical
[4] Legal Medicine Organization,Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine
[5] Al-Farahidi University,undefined
[6] Tehran University of Medical Sciences,undefined
来源
关键词
COVID-19; NLRP3; Inflammasome; Lung; Histopathology; Coronavirus;
D O I
暂无
中图分类号
学科分类号
摘要
COVID-19 is a contagious disease that attacks many organs but the lungs are the main organs affected. The inflammasome activation results in the exacerbation of inflammatory response in infectious disease. The aim of this study is to investigate the formation and activity of the NLRP3 inflammasome complex and the histopathological changes caused by the coronavirus in the lung of deceased persons with COVID-19. In total, 10 corpses; 5 corpses with no history of any infectious diseases and COVID-19 and 5 corpses with the cause of death of COVID-19 were included in this study. Lung tissue samples were harvested during autopsy under safe conditions. Fresh tissues in each group were used to measure the genes expression and proteins level of NLRP3, ASC, Caspase-1, IL-1β, IL-6 and TNF-α and a routine hematoxylin and eosin staining was performed for histological assessment. Data are represented as the means ± SD. Statistical significance difference was accepted at a p-value less than 5%. The NLRP3, ASC, Caspase-1, IL-1β, IL-6 and TNF-α genes expression and proteins level were elevated in the lung of the COVID-19 group in comparison with the control group. Histological findings presented the increasing number of polymorphonuclear leukocytes, macrophages and also pulmonary fibrosis in the lungs of corpses with the cause of death of COVID-19. High expression of NLRP3 inflammasome components and its relation with the pathophysiology of the coronavirus-infected lung suggested that targeting the NLRP3 inflammasome could be helpful in achieving a more effective treatment in patients with COVID-19.
引用
收藏
页码:883 / 890
页数:7
相关论文
共 50 条
  • [21] Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity
    Courjon, Johan
    Dufies, Oceane
    Robert, Alexandre
    Bailly, Laurent
    Torre, Cedric
    Chirio, David
    Contenti, Julie
    Vitale, Sebastien
    Loubatier, Celine
    Doye, Anne
    Pomares-Estran, Christelle
    Gonfrier, Geraldine
    Lotte, Romain
    Munro, Patrick
    Visvikis, Orane
    Dellamonica, Jean
    Giordanengo, Valerie
    Carles, Michel
    Yvan-Charvet, Laurent
    Ivanov, Stoyan
    Auberger, Patrick
    Jacquel, Arnaud
    Boyer, Laurent
    BLOOD ADVANCES, 2021, 5 (05) : 1523 - 1534
  • [22] Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19
    Saeedi-Boroujeni, Ali
    Mahmoudian-Sani, Mohammad-Reza
    Nashibi, Roohangiz
    Houshmandfar, Sheyda
    Tahmaseby Gandomkari, Sima
    Khodadadi, Ali
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2021, 43 (03) : 247 - 258
  • [23] Nutraceutical Strategies for Suppressing NLRP3 Inflammasome Activation: Pertinence to the Management of COVID-19 and Beyond
    McCarty, Mark F.
    Iloki Assanga, Simon Bernard
    Lewis Lujan, Lidianys
    O'Keefe, James H.
    DiNicolantonio, James J.
    NUTRIENTS, 2021, 13 (01) : 1 - 21
  • [24] Vitamin D regulates COVID-19 associated severity by suppressing the NLRP3 inflammasome pathway
    Khalil, Bariaa
    Sharif-Askari, Narjes Saheb
    Hafezi, Shirin
    Sharif-Askari, Fatemeh Saheb
    Al Anouti, Fatme
    Hamid, Qutayba
    Halwani, Rabih
    PLOS ONE, 2024, 19 (05):
  • [25] NLRP3 inflammasome: A joint, potential therapeutic target in management of COVID-19 and fertility problems
    Bazrafkan, Mahshid
    Hosseini, Elham
    Nazari, Mahboobeh
    Amorim, Christiani Andrade
    Sadeghi, Mohammad Reza
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2021, 148
  • [26] NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity
    Amin, Saiful
    Aktar, Salma
    Rahman, Md Mijanur
    Chowdhury, Mohammed Mehadi Hassan
    MICROBES AND INFECTION, 2022, 24 (01)
  • [27] Circulatory Exosomes from COVID-19 Patients Trigger NLRP3 Inflammasome in Endothelial Cells
    Sur, Subhayan
    Steele, Robert
    Isbell, T. Scott
    Ray, Ranjit
    Ray, Ratna B.
    MBIO, 2022, 13 (03):
  • [28] Acute Lung Injury and the NLRP3 Inflammasome
    Gu, Wanjun
    Zeng, Qi
    Wang, Xin
    Jasem, Huthaifa
    Ma, Ling
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 3801 - 3813
  • [29] IKKβ is required for the formation of the NLRP3 inflammasome
    Nanda, Sambit K.
    Prescott, Alan R.
    Figueras-Vadillo, Clara
    Cohen, Philip
    EMBO REPORTS, 2021, 22 (10)
  • [30] Caging NLRP3 tames inflammasome activity
    Schroder, Kate
    Coll, Rebecca C.
    CELL, 2021, 184 (26) : 6224 - 6226